Restylane is not only about beauty. I can see that our products bring in so many other values in people’s lives as well.
Maria Molén Training & Account Manager Nordic countries

Products

Career

Press

A GLOBAL LEADER IN AESTHETIC AND CORRECTIVE TREATMENTS

Q-Med, a Galderma division, develops, manufactures and markets solutions for aesthetic and corrective treatments.

The division offers a complete worldwide portfolio in the aesthetic field including the brands Restylane, Emervel. Deflux, Solesta and Durolane are other products improving patients’ health in the corrective field.

Since 2011, Q-Med is wholly owned by Galderma, a pharmaceutical company with nearly 4 000 employees specialized in dermatology and present in more than 70 countries. The site in Uppsala, Sweden, is  Galderma’s Global Center of Excellence for aesthetic and Corrective solutions with state-of-the-art research, development and manufacturing.

For more information about Galderma, please visit www.galderma.com

 

Restylane logo  Visit Restylane
 Visit Emervel
 Visit Macrolane

News

2012-11-01 Q-Med saves electricity “Even if you are good, you can be even better,” says Patrik Lassegård at Q-Med. “We do not intend to rest on our laurels. There is a lot left to do if we are to become more environmentally friendly.” The idea of the Energy Optimization Project that Q-Med is running together with Vattenfall, a Swedish electricity company, is quite simply a natural continuation of work that began by changing to LED light bulbs in the canteen. Read more
2012-09-06 Q-Med sponsors rehabilitation With yoga and contemplative counselling the rehabilitation group at Uppsala University Hospital have been a success with both patients and staff. “We take care of what many people think is tough – talking about those difficult questions with patients, both youngsters and adults,” says Ann-Charlotte Pellettieri, psychotherapist. Starting this year Q-Med is sponsoring the unit for a three-year period. Read more
2012-04-18 Q-Med provides update on the use of Macrolane Q-Med has decided to discontinue the breast indication for Macrolane until consensus for best practices in breast radiology examination following Macrolane treatment has been reached. Read more
Archive